Key result
Sternal-sparing mitral valve repair was not associated with worse long-term survival compared to sternotomy in adjusted populations (HR 0.85; 95% CI 0.63-1.15; P=0.301).
Why the study?
Concerns exist regarding the durability of minimally invasive mitral valve repair compared with conventional sternotomy in patients with mitral regurgitation.
Does sternal-sparing mitral valve repair improve survival, freedom from recurrent MR, and freedom from reoperation compared to sternotomy in patients with mitral regurgitation?
Meta-Analysis (n=7,596)
Does sternal-sparing mitral valve repair improve survival, freedom from recurrent MR, and freedom from reoperation compared to sternotomy in patients with mitral regurgitation?
Hazard Ratio: 0.29 (95% CI 0.23–0.36)
p-value: p=<0.001
Sternal-sparing mitral valve repair provides comparable long-term survival, freedom from recurrent mitral regurgitation, and freedom from reoperation compared to conventional sternotomy.
Objective: Since there are concerns about the durability of mitral valve repair (MVRp) with minimally invasive techniques in patients with mitral regurgitation (MR), we aimed to evaluate the long-term outcomes of these sternal-sparing approaches when compared with conventional approaches with sternotomy in patients undergoing MVRp. Methods: We performed a systematic review according to a preestablished protocol and performed a pooled analysis of Kaplan–Meier–derived reconstructed time-to-event data from studies with longer follow-up comparing sternal-sparing versus sternotomy approaches for MVRp. Our outcomes of interest were survival, freedom from recurrent MR, and freedom from reoperation. Results: Eleven studies met our eligibility criteria comprising 7,596 patients with follow-up (sternal sparing, n = 4,246; sternotomy, n = 3,350). Patients who underwent sternal-sparing MVRp had a significantly lower risk of mortality over time compared with patients who underwent MVRp with sternotomy (hazard ratio [HR] = 0.29, 95% confidence interval [CI]: 0.23 to 0.36, P < 0.001) in the overall analysis. However, we found no statistically significant difference between the groups in the sensitivity analysis with adjusted populations (HR = 0.85, 95% CI: 0.63 to 1.15, P = 0.301). Regarding the outcomes freedom from recurrent MR and freedom from reoperation, we found no statistically significant differences between the groups in the follow-up in both overall and sensitivity analyses. Conclusions: In comparison with MVRp with sternotomy approaches, sternal-sparing MVRp was not associated with worse outcomes in terms of survival, recurrent MR, and reoperations over time.
No takes yet. Share an insight, caveat, or question.
Sá et al. (2023) conducted a meta-analysis in mitral regurgitation (n=7,596). Sternal-sparing mitral valve repair vs. Mitral valve repair with sternotomy was evaluated on mortality over time (HR 0.29, 95% CI 0.23 to 0.36, p=<0.001). Sternal-sparing mitral valve repair was not associated with worse long-term survival compared to sternotomy in adjusted populations (HR 0.85; 95% CI 0.63-1.15; P=0.301).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: